---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-119717"
form_type: "8-K"
ticker: "ABT"
cik: "0000001800"
company_name: "ABBOTT LABORATORIES"
filed_at: "2024-11-15T23:59:59+00:00"
generated_at: "2026-05-29T23:51:38.898708+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Abbott extends change-in-control agreements for NEOs through Dec 2026

## Summary
- Agreements previously set to expire Dec 31, 2024, now extended to Dec 31, 2026.
- Notification given to named executive officers on November 12, 2024.
- Extension automatically continues term through second anniversary of original expiration date.

## SEC filing metadata
- accession: 0001104659-24-119717
- form_type: 8-K
- ticker: ABT
- cik: 0000001800
- company_name: ABBOTT LABORATORIES
- filed_at: 2024-11-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800/000110465924119717/0001104659-24-119717-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800/000110465924119717/tm2428216d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-119717
- JSON: https://secwatch.observer/filing/0001104659-24-119717.json
- Plain text: https://secwatch.observer/filing/0001104659-24-119717.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.